Pfizer and BioNTech to seek approval of booster dose for those aged 16 to 17

Pfizer and BioNTech are expected to seek authorization this week for a Covid-19 vaccine booster for teens 16 and 17 years old, SİA informs, citing foreign media.

If approved, the additional Pfizer-BioNTech shot would mark the first vaccine booster for teens younger than 18.

The move comes as a new variant of coronavirus, known as omicron, spreads around the globe, worrying experts and pushing President Joe Biden to urge caution and again implore Americans to get inoculated.

Bütün xəbərlər Facebook səhifəmizdə